TY - JOUR
T1 - Targeting the adrenomedullin-2 receptor for the discovery and development of novel anti-cancer agents
JO - Expert Opinion on Drug Discovery
UR - https://eprints.whiterose.ac.uk/id/eprint/190521
PY - 2022/06/22
AU - Jailani ABA
AU - Bigos KJA
AU - Avgoustou P
AU - Egan JL
AU - Hathway RA
AU - Skerry TM
AU - Richards GO
ED -
DO - DOI: 10.1080/17460441.2022.2090541
PB - Taylor & Francis
VL - 17
IS - 8
SP - 839
EP - 848
Y2 - 2025/05/04
ER -